BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Hepatology

The World Journal of Hepatology (WJH) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of hepatology.  It was launched on October 31, 2009 and is published monthly (36 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage hepatologists worldwide to submit manuscripts to the WJH describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJH are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks.The WJH’s acceptance rate: 51%. Submit here >>

2017 Published Issues
15 14 13 12 11 10 9 8 7 6 5 4 3 2 1
Editors-in-Chief

Clara Balsano, PhD, Professor; Wan-Long Chuang, MD,PhD, Doctor,Professor

Indexing/Abstracting

PubMed, PubMed Central, Emerging Sources Citation Index(Web of Science), and Scopus.

Journal Metrics

SJR (SCImago Journal Rank) (2015): 0.858; IPP (Impact per Publication) (2015): 2.730; SNIP (Source Normalized Impact per Paper) (2015): 1.206; and CiteScore (2015) 3.19.

ISSN

1948-5182 (online)

Minireviews
Coffee: The magical bean for liver diseases  
Ryan D Heath, Mihir Brahmbhatt, Asli C Tahan, Jamal A Ibdah, Veysel Tahan
World J Hepatol 9(15):689-696. Published online May 28, 2017. doi: 10.4254/wjh.v9.i15.689
Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do  
Yolanda Sanchez-Torrijos, Javier Ampuero, Manuel Romero-Gómez
World J Hepatol 9(15):697-703. Published online May 28, 2017. doi: 10.4254/wjh.v9.i15.697
Observational Study
Trend of hepatocellular carcinoma incidence after Bayesian correction for misclassified data in Iranian provinces  
Nastaran Hajizadeh, Ahmad Reza Baghestani, Mohamad Amin Pourhoseingholi, Sara Ashtari, Zeinab Fazeli, Mohsen Vahedi, Mohammad Reza Zali
World J Hepatol 9(15):704-710. Published online May 28, 2017. doi: 10.4254/wjh.v9.i15.704
Letters To The Editor
Usefulness of the MESH score in a European hepatocellular carcinoma cohort  
Xavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, Marc Bourlière
World J Hepatol 9(15):711-714. Published online May 28, 2017. doi: 10.4254/wjh.v9.i15.711